GLP Watchdog

InstaRX vs Shape Vantage

Neither InstaRX nor Shape Vantage has an FDA warning letter on record. No price lines up like for like. They share compounded tirzepatide injection, but InstaRX's $265 is a 12-month prepaid rate, while Shape Vantage's $199.67 is a 3-month prepaid rate.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

InstaRX / Shape Vantage

InstaRX logo

InstaRX

7.7/10

Shape Vantage logo

Shape Vantage

7.0/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$265/moCompounded tirzepatide injection, 12-month prepaid plan
$199.67/moCompounded tirzepatide injection, 3-month prepaid plan
States
All 50 states and DC
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit InstaRXFull review
Visit Shape VantageFull review

Neither InstaRX nor Shape Vantage pays us. Links to them earn nothing. Scores: InstaRX 7.7, Shape Vantage 7.0. How we are paid

What the record shows

  1. 01

    Neither InstaRX nor Shape Vantage has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    No price lines up like for like. They share compounded tirzepatide injection, but InstaRX's $265 is a 12-month prepaid rate, while Shape Vantage's $199.67 is a 3-month prepaid rate.

  4. 04

    InstaRX lists all 50 states and DC. Shape Vantage publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

InstaRX

Shape Vantage

Compounded tirzepatide injection

$265/mo

12-month prepaid plan; not compared

$199.67/mo

3-month prepaid plan; not compared

Price includes
Medication, clinician visits, shipping
Not stated
Minimum term
12-month prepayment for the advertised price
Not stated
Refunds
Shipped orders cannot be returned or exchanged
Not stated

Read off each seller’s own pages. InstaRX: October 26, 2026. Shape Vantage: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for InstaRX

7.7/10

The record gives InstaRX no edge on this pair.

  • Names no compounding pharmacy
  • Lowest price is a 12-month prepaid rate
Visit InstaRX

The case for Shape Vantage

7.0/10

The record gives Shape Vantage no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list
  • Lowest price is a 3-month prepaid rate
Visit Shape Vantage

Scores

InstaRX 7.7 · Shape Vantage 7.0 out of 10. Six weighted parts.

Value25%

4.6A
vs
B
6.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
5.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

InstaRX vs Shape Vantage: questions

Neither InstaRX nor Shape Vantage has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
No price lines up like for like. They share compounded tirzepatide injection, but InstaRX's $265 is a 12-month prepaid rate, while Shape Vantage's $199.67 is a 3-month prepaid rate. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Neither InstaRX nor Shape Vantage pays us. Links to them earn nothing. Scores: InstaRX 7.7, Shape Vantage 7.0.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register